⏳ Fetching live dividend data...
Home › Calculator › IFRX Dividend Calculator 2026
InflaRx N.V. · NASDAQ
Price: $2.27 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in IFRX → $5.55M in 10 years · $216,491.60/month
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company also develops INF904, an oral, small molecule drug candidate for the undisclosed chronic inflammatory and autoimmune diseases; and IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IFRX position with:
Real after-tax yield depends on where you live and how you hold IFRX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 88.11% | 85.31% | $8,811 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 74.89% | 72.09% | $7,489 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 70.49% | 67.69% | $7,049 / yr |
| 🇬🇧 UK ISA | 0% | 88.11% | 85.31% | $8,811 / yr |
| 🇬🇧 UK Taxable | 8.75% | 80.40% | 77.60% | $8,040 / yr |
| 🇨🇦 TFSA | 0% | 88.11% | 85.31% | $8,811 / yr |
| 🇨🇦 CA Taxable | 25% | 66.08% | 63.28% | $6,608 / yr |
| 🇦🇺 Super (pension) | 15% | 74.89% | 72.09% | $7,489 / yr |
| 🇦🇺 AU Taxable | 30% | 61.68% | 58.88% | $6,168 / yr |
| 🇩🇪 DE Taxable | 26.375% | 64.87% | 62.07% | $6,487 / yr |
| 🇫🇷 FR Taxable | 30% | 61.68% | 58.88% | $6,168 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IFRX pays quarterly — 4 times per year. Next ex-div: TBD.
How IFRX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IFRX sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Other | 2026-03-18 | 7,308 | $0.01 | $96.00 | ||
| Other | 2026-03-18 | 30,000 | $1.86 | $55.8K | ||
| Other | 2026-03-18 | 30,000 | $2.37 | $71.1K | ||
| Other | 2026-03-18 | 30,000 | $1.79 | $53.7K | ||
| Other | 2026-03-18 | 30,000 | $2.41 | $72.3K | ||
| Other | 2026-03-18 | 30,000 | $1.17 | $35.1K | ||
| Other | 2026-03-18 | 30,000 | $1.86 | $55.8K | ||
| Other | 2026-03-18 | 30,000 | $2.37 | $71.1K | ||
| Other | 2026-03-18 | 30,000 | $1.79 | $53.7K | ||
| Other | 2026-03-18 | 30,000 | $2.41 | $72.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IFRX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →